Abstract We previously demonstrated that angiotensin II (Ang II) receptor signaling is involved in azoxymethaneinduced mouse colon tumorigenesis. In order to clarify the role of Ang II in COX-2 expression in the intestinal epithelium, the receptor subtype-specific effect on COX-2 expression in a rat intestinal epithelial cell line (RIE-1) has been investigated. Ang II dose-and time-dependently increased the expression of COX-2, but not COX-1 mRNA and protein. This stimulation was completely blocked by the AT 1 receptor antagonist but not the AT 2 receptor antagonist. Ang II and lipopolysaccharide (LPS) additively induced COX-2 protein in RIE-1 cells, whereas the LPSinduced COX-2 expression was significantly attenuated by low concentrations of Ang II or the AT 2 agonistic peptide CGP-42112A only in AT 2 over-expressed cells. These data indicate that Ang II bi-directionally regulates COX-2 expression via both AT 1 and AT 2 receptors. Control of COX-2 expression through Ang II signaling may have significance in cytokine-induced COX-2 induction and colon tumorigenesis.
Introduction
Prostaglandins (PGs) play an important role in a broad range of physiological processes. Alterations in its production are implicated in pathophysiological processes, including angiogenesis, cancer, acute, and chronic inflammation, etc. [1, 2] . Cyclooxygenase (COX) is the rate limiting enzyme catalyzing the conversion of arachidonic acid into prostaglandins and others eicosanoids, critically implicated in a variety of physiological and pathophysiological processes, including inflammation, vascular and renal homeostasis, and immune responses [3] . Since the early 1990s, the existence of two isoforms of cyclooxygenases (COX-1 and COX-2) has been appreciated. COX-1 and COX-2 are recognized as constitutive and inducible COX isoenzymes, respectively. Conventional findings show that the therapeutics effects of non-steroidal antiinflammatory drugs (NSAIDs such as aspirin and ibuprofen) are mostly dependent on COX-2 inhibition; therefore, agents that selectively inhibit COX-2 over COX-1 are desirable for treatment of inflammation [4] . Increased expression of COX-2 and prostaglandins has been widely observed in human [5] and rodent intestinal tumors [6, 7] when compared with normal adjacent mucosa, whereas COX-1 expression is not differentially expressed. Among the consequences of elevated COX-2 expression and increased prostaglandin production are stimulation of angiogenesis, inhibition of apoptosis, and stimulation of cellular proliferation, all of which favor tumorigenesis [8] .
Colorectal cancer is a major cause of death in developed countries, even though its prognosis has improved yearly due to advances in diagnostic and surgical techniques. Many reports indicate that the intake of NSAIDs decreases the risk of developing colorectal cancer in man [9] and in model animals [10, 11] . Inhibitors of COX-2 activity, such as aspirin, NSAIDs, and specific COX-2 antagonists, significantly reduce the occurrence of colorectal carcinoma in both animal and human studies [12] . Studies on the mechanism by which NSAIDs decrease the risk of colorectal cancer suggests that inhibition of prostaglandin synthesis by cyclooxygenase-2 (COX-2) is the major mechanism in this chemoprevention [13, 14] . Therefore, the ideal procedure in the prevention of colorectal cancer is to keep prostaglandin levels low. However, few studies have reported on the endogenous negative regulation of prostaglandin production except with the use of non-specific drugs such as dexamethasone [15] .
It has been suggested that angiotensin-converting enzyme inhibitors that are commonly employed in the treatment of human clinical hypertension also attenuate tumor growth in experimental animals [16] [17] [18] [19] and may reduce the risk of several human cancers [20] . Angiotensinconverting enzyme inhibitors block the formation of angiotensin II (Ang II), an octapeptide that exerts the many diverse effects of the renin-angiotensin system through its receptors [21] . This suggests that Ang II may have a modulating role in neoplasia. We recently demonstrated that Ang II type 2 receptor (AT 2 )-mediated signaling is involved in azoxymethane-induced mouse colon tumorigenesis [22] . Ang II, the effector of the renin-angiotensin system, has been shown to stimulate the release of prostaglandins in a variety of cells, including intestinal epithelial cells [23, 24] . Ang II-dependent increase of prostaglandin production has shown to be mediated through its type 1 receptor (AT 1 ) via the stimulation of COX-2 induction in intestinal cells [25] . Although AT 1 receptor is believed to mediate most of the cardiovascular actions of Ang II [26] , expression of AT 2 in the intestinal tissue is also noted [27] [28] [29] . Since AT 2 often counteracts the AT 1 -mediated Ang II signaling [30, 31] , if AT 2 signaling attenuates COX-2 induction, this might be an endogenous bidirectional regulation mechanism for COX-2 induction and resultant prostaglandin formation. This type of negative regulation is potentially an important target for the chemoprevention procedure of colorectal cancer.
In this study, we investigated whether Ang II regulates COX-2 expression in a rat intestinal cell line (RIE-1). We further examined the Ang II receptor subtype-specific role in this pathway.
Materials and methods

Chemicals and reagents
Ang II, (Sar 1 , Ile 8 )-Ang II, AT 2 receptor antagonist PD123319, AT 2 receptor agonist CGP-42112A, and lipopolysaccharides (LPS) from Escherichia coli were purchased from Sigma-Aldrich (St. Louis, MO). The AT 1 receptor antagonist losartan was obtained from the pharmacy at Vanderbilt University Medical Center. The antimurine COX-2 polyclonal antibody and anti-mouse COX-1 monoclonal antibody were purchased from Cayman Chemical (Ann Arbor, MI). The actin monoclonal antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Cell culture
Rat intestinal epithelial (RIE-1) cells were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 100,000 U/l penicillin G, and 100,000 lg/l streptomycin sulfate. For all experiments, 90-95% confluent cultures were tendered quiescent by incubation in serum-free DMEM for 72 h before Ang II stimulation.
RNA extraction and RT-PCR
Total cellular RNA was extracted from confluent RIE-1 cells cultured in serum-free medium by TRIzol (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol and was quantified by measurement of absorbance at 260 nm in a spectrophotometer. Two micrograms of total RNA was subjected to first-strand cDNA synthesis using the oligo-dT primer and Ominiscript RT kit (Qiagen, Valencia, CA). The primer sets for the AT 1 Expression of COX-2 in AT 2 transfected RIE-1 cell
In this study, cells were transfected with AT 2 cDNA using the AT 2 adenoviral vector as described elsewhere. In brief, the RIE-1 cells (3 9 10 5 /well) were plated in a 6-well tissue culture plate and incubated for 48 h (90-95% confluent). Cells were infected with an adenovirus vector encoding mouse AT 2 (Ad-AT 2 ) or an adenovirus encoding LacZ (Ad-LacZ) with the adenoviral vectors MOI of 50 in 200 ll of DMEM for 6 h at 37°C. After washing with PBS, the cells were incubated with 10% FBS-containing DMEM for 18 h and then serum free DMEM for 48-96 h. Cells were stimulated with various stimuli such as Ang II, CGP-42112A, or LPS (5 lg/ml) for 6-8 h. The AT 1 -specific antagonist losartan (10 -6 M) or AT 2 -specific antagonist PD123319 (10 -6 M) were added 30 min prior to the addition of stimuli. After stimulation cells were harvested and subjected to Western blot analysis for COX-2, GAP-DH, or actin as described above.
Statistical analysis
Data obtained from the RT-PCR and Western blot analysis were presented as means ± S.E (standard error). Statistical significance between groups was evaluated by one-way ANOVA with the Student-Newman-Keuls test. A value of P \ 0.05 was considered significant.
Results
Both Ang II receptor subtypes were detected in RIE-1 cells
In order to evaluate the status of Ang II receptor expression in RIE-1-cells, the expression levels of both mRNA and functional proteins of the two receptor subtypes were determined by RT-PCR and radioligand-receptor-binding assay, respectively (Fig. 1) . Expression level of AT 1 mRNA was abundant whereas the level of AT 2 mRNA was approximately 10% of the AT 1 expression levels. Expression levels of the functional AT 1 and AT 2 receptor proteins were revealed to be 226 and 12 fmol/mg protein, respectively. These data indicate that the rat intestinal epithelial cell line RIE-1 cells express a large amount of AT 1 but a small amount of AT 2 . Since the expression level of AT 2 in adult tissues is known to be small but it is inducible [33] , this cell line appears to be an appropriate cell line to study the effect of Ang II on cyclooxygenase expression.
Ang II stimulated COX-2 but not COX-1 expression through AT 1 receptor Ang II increased COX-2 protein expression in RIE-1 cells in a concentration dependent manner, as evaluated by Western blot analysis (Fig. 2a) . Ang II (10 -9 M) timedependently increased COX-2 mRNA and protein level as shown in Fig. 2b and c, respectively, but not COX-1 protein level. The COX-2 mRNA response was observed as early as 30 min after Ang II treatment and the maximal increase was observed 1 h after treatment. Ang II-induced COX-2 protein expression was first seen 2 h after treatment and the maximal response was observed at 4-6 h after the treatment and lasted until 24 h after treatment ( Fig. 2c and d) .
The subtype-specific role of Ang II receptors in COX-2-induction was clarified by utilizing receptor-specific antagonists. Ang II-dependent induction of COX-2 was completely blocked by the AT 1 -specific antagonist losartan (10 -6 M) but not by the AT 2 -specific antagonist PD123319 (Fig. 3) . This result clearly indicates that Ang II stimulates COX-2 induction via AT 1 , because there is no expression of COX-2 in the presence of the AT 1 -specific antagonist losartan or both AT 1 and AT 2 -specific antagonists (Fig. 3) .
Ang II and LPS additively stimulated COX-2 expression
Although we obtained clear-cut results indicating that the Ang II stimulates COX-2 induction through the AT 1 in intestinal epithelial cells, the pathophysiological significance of Ang II in COX-2 induction is still uncertain. In . The whole homogenates were subjected to SDS-polyacrylamide gel electrophoresis followed by Western blotting with anti-murine COX-1 and COX-2 antibodies. (d) Quantification of COX-2 protein in panel C was carried out by scanning densitometry and averages of the expression levels (n = 5) normalized by actin levels are displayed in the histogram. *P B 0.05 as compared to the level of time 0 h order to address this issue, i.e., the effect of Ang II on a typical COX-2 inducer, LPS-stimulated COX-2 induction was studied. Ang II (10 -8 M) and LPS (5 lg/ml) additively increased COX-2 expression in RIE-1 cells and this additive effect was completely blocked by the AT 1 -specific antagonist losartan (Fig. 4) . These results suggest that Ang II-dependent COX-2 induction in intestinal epithelial cells is likely to have pathophysiological significance.
Ang II attenuated LPS-induced COX-2 expression through over-expressed AT 2 receptor
Since the AT 2 protein expression level in this cultured cell is smaller than those reported [27, 34] , the AT 2 protein level may not be sufficient to exhibit the AT 2 -mediated Ang II effect in COX-2 expression. In this study, the AT 2 was over-expressed by transfecting cells with AT 2 cDNA using the AT 2 adenoviral vector. In this study, the most efficient AT 2 receptor expression was observed at 4 days after transfection, and the expression of AT 2 was approximately 22% of the AT 1 expression level when 50 MOI vector was transfected (Fig. 5) . Accordingly, co-stimulation of the cells with LPS and Ang II was performed 4 days after transfection with 50 MOI AT 2 vector. Although Ang II (10 -8 M) and LPS (5 lg/ml) additively increased COX-2 expression in both untransfected (Fig. 4) and LacZ-transfected RIE-1 cells (data not shown), low concentrations of Ang II and AT 2 agonist CGP-42112A significantly attenuated LPS-induced COX-2 expression when AT 2 receptor was transfected (Fig. 6) . The attenuation effect was more pronounced when lower concentration of LPS was used for the COX-2 induction. In addition, Ang II-dependent attenuation was pronounced in the presence of the AT 1 receptor antagonist losartan (1 lg/ml, data not shown). These results suggest that Ang II attenuates LPS-induced COX-2 expression through AT 2 mediated signaling. This implies that Ang II bi-directionally regulates COX-2 expression (AT 1 stimulates, but AT 2 attenuates COX-2 induction). 
Discussion
It has been suggested that Ang II signaling may play important roles in tumorigenesis in several tissues [17, 20, [35] [36] [37] [38] [39] . However, the specific role of the Ang II receptors in tumorigenesis has not been elucidated. We have previously demonstrated a pro-oncogenic role of the AT 2 receptor in chemical carcinogen azoxymethane-induced colon tumorigenesis [37] and tobacco-specific nitrosamineinduced lung tumorigenesis [39] . In the present study, we used cultured normal intestinal epithelial cells to clarify the roles of Ang II and its receptors in cyclooxygenase induction in intestine. Cyclooxygenases are the rate-limiting enzymes for the prostaglandin formation and have been reported to be associated with human colon cancer development [14, 40, 41] and other chronic bowel diseases [42] . Elucidation of the role of Ang II and its receptors in colon tumorigenesis-associated cyclooxygenases are important in understanding the of upstream regulation of this enzyme.
First, we examined the Ang II receptor expression status of the rat intestinal epithelial cell line, which was utilized for the present study, using RT-PCR and ligand-receptorbinding assay. The present study demonstrated that the RIE-1 cell line expresses both AT 1 and AT 2 receptor mRNA's (Fig. 1a) . However, the proportion of the AT 1 protein was significantly larger than that of the AT 2 protein (Fig. 1b) . Proportion of the AT 2 receptor expression levels seems smaller than the previous measurement of the receptor expression in intestinal mucosa in vivo [27] . However, this result seems reasonable, since AT 2 expression is suppressed during cell culture but is inducible by removing serum from the culture medium [34] . Indeed, AT 2 protein expression in RIE-1 cells was noticeably increased by serum removal (data not shown). Therefore, the present study with cultured cells of RIE-1 should be a good model system to evaluate the role of Ang II in COX expression in intestinal epithelial cells.
In view of that, we evaluated the effect of Ang II on the expression of the COX-2 expression in the rat intestinal epithelial cell line using RT-PCR and Western blot analysis. The results clearly demonstrated that Ang II, doseand time-dependently stimulated COX-2 but not COX-1 expression in the RIE-1 cell line (Fig. 2) . The present study also indicates that the Ang II AT 1 -mediated signal plays the primary role in COX-2 induction. These results are in good agreement with a recent report in which Ang II stimulates COX-2 expression in non-transformed rat intestinal cell line [25] . Slice et al have shown that Ang II potently stimulated expression of COX-2 mRNA and protein as an early gene response through the Ang II type 1 receptor.
Although the present study also strongly suggests that AT 1 plays a critical role in Ang II-dependent COX-2 induction in intestinal epithelium, involvement of another Ang II receptor subtype in this reaction is unclear since the RIE-1 cell line expresses only a limited amount of AT 2 ( Fig. 1) . Therefore, the effect of Ang II on COX-2 expression was re-evaluated in the RIE-1 cell line expressing higher levels of AT 2 . As demonstrated in Fig. 5 , the AT 2 transfected cells express much higher levels of the AT 2 protein in the cells. Although Ang II alone did not alter COX-2 expression in these cells, Ang II significantly attenuated the effect of a most powerful stimulator LPSinduced COX-2 expression (Fig. 6 ) and this attenuation was also mimicked by AT 2 agonist CGP-42112A. These results clearly demonstrated that the presence of the AT 2 receptor is potentially important in the regulation of COX-2 expression. This notion is potentially important, since tumor tissue consists of a variety of cell types such as infiltrated lymphocytes, macrophages, fibroblasts, and endothelial cells. These cells seem to play an important role in tumor cell growth, invasion, metastasis, angiogenesis, and evasion of the host immune system [43] . Prostaglandins and various cytokines produced either in tumor cells or stromal cells are involved in many of these biological reactions [14, [43] [44] [45] . Although a number of reports have described the role of Ang II in intestinal sodium and water absorption function [46, 47] , only a few reports describe subtype-specific Ang II receptor expression in the intestine [27, 29, 47] . AT 2 receptor has been shown to be involved in absorption/ secretion of water and electrolytes [47, 48] , and to induce mucosal release of nitric oxide [29] . However, this receptor does not influence smooth muscular contractions [49, 50] . Since Ang II has similar affinity to both of its receptor subtypes, it is suggested that in most cases the AT 1 receptor counteracts AT 2 receptor-mediated effects. Johansson et al. have shown such an antagonistic relationship, in which activation of AT 1 receptor contributes to inhibition and AT 2 receptor stimulates duodenal mucosal alkaline secretion [51] . In terms of the potential mechanism by which AT 2 receptor signaling antagonizes AT 1 receptor signaling, it has been reported that AT 2 receptor signaling stimulates tyrosine phosphatase, thus antagonizing AT 1 receptormediated actions [52] [53] [54] . It is also reported that the AT 2 receptor directly interacts with the AT 1 receptor, thus counteracting its specific function [22, 55] . Accordingly, the overall response to Ang II in COX-2 induction is the AT 1 receptor-mediated stimulation as shown in Figs. 2 and  3 ; this response may be modulated in part by AT 2 receptormediated signaling via regulation of de-phosphorylation of AT 1 receptor-dependent phosphoproteins or direct interaction of both receptor proteins.
On the other hand, it is difficult to speculate a precise mechanism by which AT 2 receptor signaling attenuated LPS-induced COX-2 expression. However, since LPS is shown to stimulate multiple kinase activities and regulate multiple gene expression [56] [57] [58] , AT 2 receptor overexpression may have modulated LPS-dependent phosphoproteins via protein tyrosine phosphatase activation and hence attenuated LPS-dependent COX-2 protein expression. In addition, AT 2 receptor over-expression has shown to down regulate AT 1 receptor expression [22] and this may also be a part of a potential explanation for the AT 2 receptor-dependent attenuation of COX-2 protein expression. However, clarification of this mechanism needs to be evaluated by another study.
In summary, the present study demonstrated a bidirectional regulatory function of the Ang II receptors in cyclooxygenase-2 expression in non-transformed rat intestinal epithelial cell line. Since pharmacological control of the Ang II receptor function in vivo is a viable therapeutic technique [59] , it is feasible to determine whether AT 1 receptor blockers attenuate colorectal tumorigenesis. Increasing AT 2 expression in intestinal epithelium, which attenuates COX-2 expression, may also be a potential route for chemoprevention of colorectal cancer. This may leads to the development of a potential chemoprevention procedure for human colorectal cancer. However, the importance of the Ang II receptor function in human colorectal cancer awaits further study. To the best of our knowledge, the present study is the first to demonstrate that the Ang II AT 2 possesses a modulator function in COX-2 expression in intestinal cells.
